Figures & data
Figure 1 Sex distribution among patients with COPD, ACOS, and asthma (%).
![Figure 1 Sex distribution among patients with COPD, ACOS, and asthma (%).](/cms/asset/0b126769-d970-4a2d-a18c-26f3ccb737b8/dcop_a_92331_f0001_b.jpg)
Figure 2 Smoking habits among patients with COPD, ACOS, and asthma (%).
![Figure 2 Smoking habits among patients with COPD, ACOS, and asthma (%).](/cms/asset/9fc2ac3b-ca35-4668-853e-b6c48d4a9d22/dcop_a_92331_f0002_b.jpg)
Table 1 Baseline characteristics and prebronchodilator lung function values in patients with COPD, ACOS, and asthma controls
Table 2 Lung function values after inhalation of 400 µg salbutamol via Easyhaler dry powder inhaler
Figure 3 Reversibility in patients with COPD, ACOS, and asthma (%).
![Figure 3 Reversibility in patients with COPD, ACOS, and asthma (%).](/cms/asset/80406db0-cb1a-4b66-8f03-41297ce507c1/dcop_a_92331_f0003_b.jpg)
Figure 4 Reversibility in relation to smoking habits in patients with COPD, ACOS, and asthma (%).
![Figure 4 Reversibility in relation to smoking habits in patients with COPD, ACOS, and asthma (%).](/cms/asset/a28ee882-dd6e-45a5-b428-e88a93a3b773/dcop_a_92331_f0004_b.jpg)
Table 3 Characteristics of reversible and nonreversible patients with COPD